People
Cyteir Therapeutics snagged $29 million and a new chief executive officer as the company pushes forward to develop small-molecule inhibitors in the fight against cancer.
Giuseppe Ciaramella, formerly chief scientific officer of Moderna Therapeutics’ Valera unit, has left for an unidentified stealth-mode biotech startup.
Days before his sentencing for a criminal fraud conviction disgraced pharma entrepreneur Martin Shkreli has been ordered to forfeit $7.36 million.
After 35 years at the helm of Parexel International Corporation, co-founder Josef von Rickenbach is stepping down from his role as chief executive officer.
David Lucchino, chief executive officer of Frequency Therapeutics, is expected to be named the next chairman of MassBio next month.
Martin Shkreli will be responsible for $10.4 million in financial losses when he faces sentencing for defrauding hedge fund investors on March 9.
Vertex Pharmaceuticals announced that Reshma Kewalramani will be the new chief medical officer and executive vice president, Global Medicines Development and Medical Affairs
The proverbial glass ceiling for women in biotech has some cracks but it may not yet have shattered – particularly in the Bay Area hotbed.
The news was revealed in a filing with the SEC.
The 60-year-old chemist has been charged with stealing 219.79 grams of potassium cyanide from a Merck facility in Pennsylvania.
PRESS RELEASES